Analysis various definition of economic? which of these definitions do you like most? give reason?
Answers
Bharat Biotech's Covaxin is likely to be the only vaccine available for children between the age of 15 and 18 years, though Zydus Cadila's vaccine ZyCoV-D has also been approved by the country's apex drug controller body for administration among children, news agency PTI reported. ZyCoV-D was the first vaccine to have received the nod for administration on children but it may not be part of the immunisation programme starting from January 3 as it has not yet been introduced even for adults.
ZyCov-D, the world's first DNA-based needle-free vaccine received emergency use authorisation from the drug controller on August 20. On December 25, Bharat Biotech's Covaxin received the go-ahead from the drug controller and on the same day, PM Modi announced India's vaccination programme for children
Explanation:
Bharat Biotech's Covaxin is likely to be the only vaccine available for children between the age of 15 and 18 years, though Zydus Cadila's vaccine ZyCoV-D has also been approved by the country's apex drug controller body for administration among children, news agency PTI reported. ZyCoV-D was the first vaccine to have received the nod for administration on children but it may not be part of the immunisation programme starting from January 3 as it has not yet been introduced even for adults.
ZyCov-D, the world's first DNA-based needle-free vaccine received emergency use authorisation from the drug controller on August 20. On December 25, Bharat Biotech's Covaxin received the go-ahead from the drug controller and on the same day, PM Modi announced India's vaccination programme for childre. Write a note or summary of the following paragraph:
Bharat Biotech's Covaxin is likely to be the only vaccine available for children between the age of 15 and 18 years, though Zydus Cadila's vaccine ZyCoV-D has also been approved by the country's apex drug controller body for administration among children, news agency PTI reported. ZyCoV-D was the first vaccine to have received the nod for administration on children but it may not be part of the immunisation programme starting from January 3 as it has not yet been introduced even for adults. ZyCov-D, the world's first DNA-based needle-free vaccine received emergency use authorisation from the drug controller on August 20. On December 25, Bharat Biotech's Covaxin received the go-ahead from the drug controller and on the same day, PM Modi announced India's vaccination programme for children.